Doporuèení Èeské revmatologické spoleènosti pro léèbu revmatoidní artritidy. Úèinnost a strategie léèby

T Sokka, J S Smolen, F C Breedveld, T Pincus, A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures. Clinical and Experimental Rheumatology. ,vol. 21, ,(2003)

G Triadafilopoulos, G Singh, Epidemiology of NSAID induced gastrointestinal complications. The Journal of Rheumatology Supplement. ,vol. 56, pp. 18- 24 ,(1999)

JOACHIM R Kalden, DAVID L Scott, JOSEF S Smolen, MANFRED Schattenkirchner, BLAZ Rozman, BRYAN D Williams, TORE K Kvien, PETER Jones, RICHARD B Williams, Christine Oed, Ronald Rosenburg, European Leflunomide Study Group, None, Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. The Journal of Rheumatology. ,vol. 28, pp. 1983- 1991 ,(2001)

Vivian Welch, Lucie Brosseau, Lynn Casimiro, Maria Judd, Beverley Shea, Peter Tugwell, George A Wells, Thermotherapy for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews. ,(2002) , 10.1002/14651858.CD002826

B. Combe, M. Dougados, P. Goupille, A. Cantagrel, J. F. Eliaou, J. Sibilia, O. Meyer, J. Sany, J.-P. Daur�s, A. Dubois, Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis & Rheumatism. ,vol. 44, pp. 1736- 1743 ,(2001) , 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I

Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman, Charles A. Birbara, Leah A. Teoh, Steven A. Fischkoff, Elliot K. Chartash, Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis & Rheumatism. ,vol. 48, pp. 35- 45 ,(2003) , 10.1002/ART.10697

J�rg J. Goronzy, Eric L. Matteson, James W. Fulbright, Kenneth J. Warrington, April Chang-Miller, Gene G. Hunder, Thomas G. Mason, Audrey M. Nelson, Robert M. Valente, Cynthia S. Crowson, Henry A. Erlich, Rebecca L. Reynolds, Ronald G. Swee, W. Michael O'Fallon, Cornelia M. Weyand, Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis & Rheumatism. ,vol. 50, pp. 43- 54 ,(2004) , 10.1002/ART.11445

James F. Fries, Patricia Spitz, R. Guy Kraines, Halsted R. Holman, Measurement of patient outcome in arthritis Arthritis & Rheumatism. ,vol. 23, pp. 137- 145 ,(1980) , 10.1002/ART.1780230202

Ravinder Maini, E William St Clair, Ferdinand Breedveld, Daniel Furst, Joachim Kalden, Michael Weisman, Josef Smolen, Paul Emery, Gregory Harriman, Marc Feldmann, Peter Lipsky, Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial The Lancet. ,vol. 354, pp. 1932- 1939 ,(1999) , 10.1016/S0140-6736(99)05246-0

James R. O'Dell, Robert Leff, Gail Paulsen, Claire Haire, Jack Mallek, P. James Eckhoff, Ana Fernandez, Kent Blakely, Steven Wees, Julie Stoner, Stephen Hadley, Jeffrey Felt, William Palmer, Paul Waytz, Melvin Churchill, Lynell Klassen, Gerald Moore, Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two-year, randomized, double-blind, placebo-controlled trial Arthritis & Rheumatism. ,vol. 46, pp. 1164- 1170 ,(2002) , 10.1002/ART.10228